This website is intended only for qualified researchers, scientific professionals, laboratories, academic institutions, and authorised commercial research organisations.
Vora Health products are manufactured in an FDA-registered, cGMP-compliant laboratory and supplied strictly for in vitro laboratory research use only.
I am 18 years of age or older, and I am a qualified researcher, scientific professional, laboratory representative, academic institution, or authorised commercial research purchaser.
All products supplied by Vora Health are sold strictly for in vitro laboratory research use only, and are not supplied as medicines, food supplements, cosmetics, medical devices, or consumer health products.
While products may be manufactured in an FDA-registered, cGMP-compliant laboratory, this does not mean the products have been assessed, authorised, licensed, or approved by the MHRA, the FDA, or any other regulatory authority for human or veterinary use. This website does not provide medical advice, clinical guidance, diagnosis, treatment, prescribing advice, or recommendations for human use — product information is provided for technical, educational, and informational research purposes only, and no claims are made regarding safety, efficacy, therapeutic benefit, or clinical outcomes.
It is my responsibility to ensure that any purchase, possession, handling, storage, importation, transfer, or use of these products complies with all applicable laws, regulations, institutional requirements, and laboratory safety procedures in my jurisdiction.
By continuing, you confirm that you agree to the statements above and acknowledge the Disclaimer, Terms of Service, Privacy Policy, and Cookie Policy.

BPC-157 / TB-500 Blend 5mg / 5mg
Two research compounds, co-formulated in one vial.
£39.95
This Vora formulation combines BPC-157 and TB-500 in a single vial: 5mg of each compound, 10mg total. It is a blend, not a bundle of two separate vials, and is supplied for controlled in vitro research.
Vial specification: 5mg / 5mg per vial. Single blended vial. BPC-157: 5mg. TB-500: 5mg. Total nominal content: 10mg. The formulation must be assessed using documentation specific to the blend.
Supplied by Vora Labs for in vitro laboratory research only. Not for human or veterinary use, consumption or administration. Not supplied as a medicine, supplement or cosmetic. No treatment, cure or personal outcome is intended or implied.
Temporary illustrative image: the photograph shows a BPC-157 / TB-500 example vial. Its label, strength and wording do not describe or certify this product; refer to this listing and the applicable batch documentation.
For research use only. This product is not intended to diagnose, treat, cure, or prevent any disease. Manufactured in an FDA-approved facility. UK-dispatched.
BPC-157 and TB-500 appear in experimental literature concerning tissue-associated signalling, cell migration and cytoskeletal regulation. A co-formulated material also raises distinct questions about analytical separation, stability and interpretation of multi-compound assays. Evidence concerning an individual constituent cannot establish the behaviour of the blend. No synergy, injury recovery or tissue-healing outcome is claimed.
Research findings must be read in the context of their methods, controls and limitations. The vial content is a material specification, not a dosing instruction. Handling and storage should follow the supplied documentation and the laboratory’s validated procedures.